AYTU BIOPHARMA, INC - AYTU
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | LYTTON LAURENCE W | 9.99% | 1,071,351 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | LYTTON-KAMBARA FOUNDATION | 8.8% | 895,528 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | AWM Investment Company, Inc. | 5.8% | 619,574 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | LYTTON LAURENCE W | 9.99% | 1,086,522 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Lytton-Kambara Foundation | 9.99% | 1,086,522 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Philotimo Fund, LP | 0.0% | 0 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Philotimo Focused Growth & Income Fund | 0.0% | 0 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Kanen Wealth Management LLC | 0.0% | 0 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Kanen David | 0.0% | 0 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.